RobertJosephNoveckMD

Emergency Medicine • Durham, NC

Associate Professor, Medicine, Duke University School of Medicine

Join to view full profile

Dr. Noveck is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Noveck's full profile

Already have an account?

Office
200 Duke Medical Ctr
# Duke
Durham, NC 27710
Phone+1 919-684-1018

Fax+1 919-684-1674

Education & Training

Tulane UniversityResidency, Internal Medicine, 1982 - 1985
Louisiana State University School of Medicine in New OrleansClass of 1982

Certifications & Licensure

LA State Medical License 1982 - 2025
NC State Medical License 2009 - 2025
FL State Medical License 2014 - 2019
NJ State Medical License 2005 - 2011

Clinical Trials

Effects of CS-8080 in Healthy Volunteers Start of enrollment: 2008 Jan 01
Completed
Phase 1
Open-label, Normal Healthy Volunteer Clinical Trial of a Novel Ondansetron Formulation Start of enrollment: 2010 Dec 01
Completed
Phase 1
Study of Levotofisopam 50 mg Three Times a Day (TID) Administered for 7 Days on Hyperuricemia and Gout Start of enrollment: 2012 Jan 01
Unknown status
Phase 2
The Safety Evaluation of Aminophylline and Ambrisentan When Administered Orally Alone and in Combination to Healthy Volunteers Start of enrollment: 2012 Feb 01
Completed
Phase 1
A Study to Test the Safety of Combined Dosing With Aminophylline and Ambrisentan in Exercising Healthy Human Volunteers at Simulated High Altitude Start of enrollment: 2013 Sep 01
Completed
Phase 1
Effects of a Double-Blind, Single Dose of PER977 Administered Alone, and Following a Single Dose of Edoxaban Start of enrollment: 2013 Jul 01
Completed
Phase 1
A Double-Blind Pharmacokinetic Interaction Study Evaluating the Effect of a Single IV Infusion of GGF2 or Placebo on Midazolam Pharmacokinetics in Patients With Heart Failure Start of enrollment: 2013 Sep 01
Completed
Phase 1
Variability in the Measurement of WBCT Between Blood Drawn From Indwelling Catheters and Direct Venipuncture Start of enrollment: 2014 Apr 01
Completed
Not Applicable
INC280 in Healthy Subjects With Impaired Hepatic Function and Subjects With Normal Hepatic Function Start of enrollment: 2015 Jun 12
Completed
Phase 1
A Study of LY3041658 in Participants With Skin Diseases Start of enrollment: 2016 Nov 08
Completed
Phase 1
Join now to see all

Publications & Presentations

PubMed

1 citations
Low Plasma Gelsolin Concentrations in Chronic Granulomatous Disease
John Audley, Emily F. Gliniewicz, Kol A. Zarember, Hanna S Hong, Gal Wald
Inflammation. 2021-02-01
7 citations
First-in-Human Studies of MW01-6-189WH, a Brain-Penetrant, Antineuroinflammatory Small-Molecule Drug Candidate: Phase 1 Safety, Tolerability, Pharmacokinetic, and Phar...
Linda J. Van Eldik, Lumy Sawaki, Karen Bowen, Daniel T. Laskowitz, Robert J. Noveck
Clinical Pharmacology in Drug Development. 2021-02-01
11 citations
The Potential Role of the J-Tpeak Interval in Proarrhythmic Cardiac Safety: Current State of the Science From the American College of Clinical Pharmacology and the Car...
Jose Vicente, David G. Strauss, Vijay V. Upreti, Michael J. Fossler, Philip T. Sager
Journal of Clinical Pharmacology. 2019-07-01

Professional Memberships

American College of Emergency Physicians - ACEP
Member

RobertJosephNoveckMD

Dr. Noveck is on Doximity

Education & Training

Certifications & Licensure

Clinical Trials

Publications & Presentations

Professional Memberships

Viewing the full profile is available to verified healthcare professionals only.